| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Rahko Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/ Type: | 5 | 0 | 3 | 1 |
 |  Milestone Pharmaceuticals, Inc. Headquartered in Montreal, with a growing subsidiary in Charlotte, NC Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by … Type: | 1 | 1 | 1 | 45 |
 | Sirona Biochem Corp. Advancing chemistry. Enhancing health. Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem (located in France) is the recipient of multiple French scientific awards and European Union and French government grants. Sirona Biochem is a publicly-traded company. The company is listed on the TSX Venture Exchange in Canada … Type: | 5 | 0 | 4 | 5 |
 | Ampans [Automatic translation follows] Commitment to people with intellectual disabilities AMPANS is a foundation that works to promote the education, quality of life and employment of people with intellectual disabilities, managing centers, services, programs and supports with criteria of accredited excellence. Ampans is a foundation, with 50 years of history, committed to people with intellectual disabilities and their families. We accompany and support more than 1,500 people and their families by offering continuous, flexible, adapted and close care services. The range of AMPANS services embraces all ages and adapts to all degrees of dependency. The aim of our service is to … Type: | 11 | 1 | 8 | 326 |
 | Walk With Path Limited Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. 🏔 Explore beyond possible. 🦿 Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. Product design, Medical devices, Innovation design engineering, Innovation, Parkinson's, Diabetes, Gait disorders, Data science, and Remote monitoring Type: | 16 | 6 | 12 | 14 |
 | Spindiag GmbH The infection control solution. Spindiag is a spin-off of Hahn-Schickard, one of the world’s leading research institutions for microsystems technology. Based on its patented microfluidic platform “LabDisk”, Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for respiratory pathogens such as SARS-CoV-2 or drug-resistant pathogens. Behavior guidelines: https://www.spindiag.de/social-media-netiquette/ Impressum Spindiag GmbH Daniel Mark Engesserstr. 4a 79108 Freiburg Germany Email: info@spindiag.de Phone: +49 761 203 73246 Amtsgericht Freiburg im Breisgau HRB 714527 Tax ID number: DE305897842 point-of-care testing and in-vitro diagnostics Type: | 3 | 0 | 3 | 8 |
 |  Laverock Therapeutics Programmable gene silencing to transform advanced therapies Next generation programmable cell therapies Type: | 2 | 0 | 2 | 37 |
 | Transimmune AG Restoring immune surveillance through natural immunity - a revolution in dendritic cell therapy. Transimmune AG is leading a revolution in dendritic cell therapy having uncovered how dendritic cells are made physiologically in vivo. Type: | 0 | 0 | 0 | 3 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 20 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 8 |
 | Entero Therapeutics (Nasdaq: ENTO) A biopharma company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases Entero Therapeutics, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company’s programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. For more … Type: | 2 | 0 | 2 | 13 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 6 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 157 |
 | ZEDIRA GmbH Targeting Transglutaminase for Research & Medicine! ZED1227 First Tissue Transglutaminase Inhibitor in Clinical Trials! Zedira is specialist and global brand for transglutaminase. More than 200 specialty reagents for transglutaminase-related R&D. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products – and in an increasing manner – from customised services. Solutions for site specific labeling of proteins using transglutaminases form Zedira’s latest product field. Simply - "The Transglutaminase Company" and From bench to bedside Type: | 1 | 1 | 0 | 11 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 1 | 1 | 0 | 6 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 2 | 1 | 1 | 17 |
 | Easy Medical Device Consulting Agency. Help you place your Compliant Medical Device on the market Easy Medical Device is a company that will support you to place your Medical Device on the market. With its network, the company is capable of finding you the right support you need to execute your tasks. If you have a project to develop or a problem to solve in terms of Quality and Regulatory Affairs, Easy Medical Device is your solution. We help companies that are bringing new devices on the market or companies that just need an upgrade of their system. We can also find you … Type: | 0 | 0 | 0 | 11 |
 | VectorBuilder VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to … Type: | 10 | 1 | 8 | 79 |
 | DBS System Making blood samples travel - not people. DBS System is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes. We produce devices with patent pending microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well. HemaXis will help democratize blood … Type: | 2 | 0 | 2 | 6 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 21 |
 | Q-linea At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD … Type: | 0 | 0 | 0 | 94 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 275 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 43 |
 |  MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company. Conditioning the gut ecosystem for disease prevention and therapy. Spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, aimed at shaping the intestinal microbiota for the cure and prevention of diseases such as bowel diseases and cancer. The gut ecosystem conditions the function of all our organs and plays a fundamental role in our wellbeing. The mucosal immune system has co-evolved with the intestinal microbiota to adapt its function to a number of environmental and possibly pathogenic factors. MV Bio leverages a microbiota-mediated mechanism regulating the physiological response of the intestinal … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 1 | 1 | 0 | 24 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 3 | 2 | 0 | 17 |
 | LDMH Partners Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 7 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 1 | 0 | 1 | 11 |
 | Mindi Independent Health Curator Guiding regular people into Curated Independent Healthcare, giving exclusive access to uncensored content, the very best independent medical professionals, and the most advanced treatments with no wait and extreme privacy. Telehealth, Advanced Therapeutics, Medical Content, Prescriptions, Exclusive Clinic Access, Women's Health, Men's Health, and COVID-19 Type: | 0 | 0 | 0 | 10 |
 | Landmark BioVentures AG Integrated and agile biotech hub-and-spoke company Landmark BioVentures AG (LBV), founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company. LBV takes a unique model focused on lean operations, smart capital allocation, and diversified yet complementary nexus of seven companies developing 10 first in class therapeutics. drug development , biotech, oncology, immuno-oncology, ophthalmology, immunology, pathobiology, inflammation, and business development Type: | 5 | 1 | 5 | 4 |
 | Neurentis plc NEW FRONTIERS IN NEUROSCIENCE Expertise, Experience, Innovation, Vision, Values. Neurentis PLC is a late-clinical stage UK biotech company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with 3 products: 1) an advanced lead drug candidate, a prescription pharmaceutical (selegiline), in a transdermal patch, for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development, 2) a small molecule agonist of the oxytocin receptors for the treatment of Autism, Chronic and Neuropathic Pain and addiction to alcohol and opioids and 3) … Type: | 1 | 1 | 0 | 3 |
 | ZEBRA MEDICAL Care without compromise. We go beyond the conventional role of providing medical devices. Medical device manufacturer and distributor of specialised products mainly in the fields of oncology, pain management, ultrasound and cellAED Type: | 0 | 0 | 0 | 13 |
 | IceCure Medical The Choice of Cryoablation IceCure Medical is a medical device company dedicated to providing patients and healthcare providers with the minimally invasive choice of cryoablation using liquid nitrogen for the treatment of benign and cancerous tumors. Our flagship device, the ProSense System, utilizes the power of liquid nitrogen to generate ultra-cold temperatures quickly to create large lethal zones that freeze and destroy tumors. By using liquid nitrogen, the system enables procedures to be performed in office-based settings, as there is no need for special safety precautions compared to other high-pressure gases used in cryoablation such as argon. In 2024, IceCure … Type: | 0 | 0 | 0 | 71 |
 | ObsEva SA ObsEva. Nature meets Nurture Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. Type: | 0 | 0 | 0 | 11 |
 | Silence Therapeutics plc Precision Engineered Medicines to Silence Diseases Our 20-plus years of RNAi experience together with our validated mRNAi GOLDTM platform make us a partner of choice for pharmaceutical companies looking to access the benefits of the siRNA and add this revolutionary modality to their discovery pipeline. As pioneers in the design and development of siRNAs (short interfering RNAs), Silence Therapeutics is advancing a new generation of medicines to potentially address the needs of patients who have limited or inadequate treatment options. Our mission is to use our technology to create a new generation of therapeutics which can improve outcomes for patients … Type: | 0 | 0 | 0 | 108 |
 | BioNTech IMFS BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. The company has more than 500 experienced and highly skilled employees and is always looking for motivated people! See also www.biontech-imfs.de Cell therapy, GMP manufacturing, Gene Therapy, RNA manufacturing, Retroviral vector manufacturing, Contract Manufacturing, … Type: | 0 | 0 | 0 | 251 |
 | Alzforum Alzforum, founded in 1996, is a free, dynamic, web-based scientific community dedicated to understanding Alzheimer's disease and related disorders. Our editorial priorities are as diverse as the needs of the research community. The website reports news on the latest scientific findings from basic research to clinical trials; maintains public databases of animal models, therapeutics, genetic risk factors, and biomarkers; and holds live discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer's disease. The Alzforum team of professional science writers and … Type: | 0 | 0 | 0 | 11 |
 | Seelos Therapeutics, Inc. A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare diseases. Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL". Rare Diseases, Parkinson's Disease, Sanfilippo Syndrome, Suicidality, Depression, PTSD, MDD, CNS Disorders, … Type: | 2 | 0 | 1 | 12 |
 | Cerule International Building Extraordinary Lives® with proven, cutting-edge dietary supplements and skin care products. Cerule® is a biotech company that sells proven, one of a kind dietary supplements, skin care and wellness products. Our products are validated by years of scientific research and development, patents and published scientific papers. We challenge the status quo and are constantly striving to find and develop groundbreaking health solutions that produce positive changes to help you live a longer, healthier and happier life. It is with this mission that Cerule has been positively impacting countless lives worldwide for more than a decade. We believe the extraordinary … Type: | 0 | 0 | 0 | 114 |
 | BIOSENIC S.A. New solutions for autoimmune, inflammatory and bone diseases. BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair. Cell therapy, Bone and joint tissue regeneration, Osteo-Articular Diseases, autoimmunity, immunity, autoimmune disease, and arsenic Type: | 16 | 4 | 11 | 26 |
 | ITM Isotope Technologies Munich SE Dedicated to giving cancer patients better answers than "maybe". PASSION FOR PRECISION. ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radioisotopes and generator platform for a new generation of targeted cancer diagnostics and therapies. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in … Type: | 1 | 0 | 1 | 445 |
 | ADDvise Group AB (publ) Leading supplier of equipment to healthcare and research facilities ADDvise is a leading supplier of equipment to healthcare and research facilities. ADDvise Group AB (publ) is an expanding group that offers total solutions in products and services to healthcare and research facilities through its subsidiaries. We develop and nurtures long-term relationships by offering leading edge competence in our two business units Lab and Healthcare. Our subsidiaries are divided equal into the business fields. Lab creates modern research facilities by providing laboratory furnishings, safety ventilation, climate rooms, clean rooms and laboratory apparatus to e.g. the pharmaceuticals industry and life science research. … Type: | 0 | 0 | 0 | 30 |
 | Protembis GmbH Full Cerebral Embolic Protection System to Reduce the Risk of Cerebrovascular Events during TAVR/ TAVI. Protembis is an Aachen, Germany based medical device startup. It develops a novel catheter-based filter device for use during cardiac interventions. The device is designed to minimize the risk of stroke and other neurological injury during these interventions – particularly during transcatheter aortic valve replacement procedures (TAVR/ TAVI). The filter blocks embolic debris from entering the blood vessels leading to the brain. The initial safety and feasibility of the ProtEmbo® device has been demonstrated in a first-in-human study in 2017/ 2018. The imaging data of … Type: | 0 | 0 | 0 | 22 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: | 3 | 2 | 2 | 39 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: | 0 | 0 | 0 | 26 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 1 | 0 | 0 | 5 |
 | Manina Medtech Boosting In Vitro Fertilisation Success Infertility is a global health problem, with a rising incidence, affecting one in every six couples and 190 million people worldwide. In Vitro Fertilisation (IVF), one of the most known infertility treatments, has gained awareness and clients. However, of the nearly a million IVF cycles done in Europe annually, only 40% result in pregnancy. Low IVF success makes the process long, expensive, and emotionally devastating. Manina Medtech is a young startup with a B2B business model and the vision that every woman who goes through IVF requires a single IVF cycle to get pregnant. We … Type: | 1 | 0 | 0 | 6 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 19 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, … Type: | 0 | 0 | 0 | 3 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: | 11 | 0 | 9 | 73 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 1 | 1 | 0 | 72 |
 | Circuit Clinical An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site … Type: | 10 | 1 | 6 | 101 |
 | Menten AI Building the world's most advanced generative AI platform for peptide therapeutics design. Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics. Type: | 9 | 1 | 6 | 14 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 1 | 0 | 0 | 28 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 41 | 16 | 33 | 70 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 0 | 0 | 4 |
 | Piomic Medical Advanced wound care, made personal. There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems. Piomic developed an innovative medical device for the treatment of hard-to-heal wounds. The COMS® One Therapy System is a portable, hand-held device that incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers. It integrates smoothly into the patient’s healing journey with usage in all care environments. By developing a therapy that is safe and effective we hope to set a better … Type: | 1 | 0 | 0 | 16 |
 | Cocoon Bioscience Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high performance growth factors and enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors. Type: | 2 | 1 | 1 | 29 |
 | Lymphatica Medtech Lymph Flow Matters Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium. Type: | 4 | 3 | 1 | 12 |
 |  Aerogabs Aerogabs is a consulting service for Entrepreneurs and Small & Medium Business. We boost your Company Performance by designing a Culture of Innovation. We have over 15 years of experience with a strong expertise in high-tech industries such as aerospace and medical devices. We offer 3 solutions: 1-Singularity - understands the dynamic of your territory and then adapt your posture in order to maximize your customer benefits. 2-Strategy - leverages your customer benefits by fully exploiting your potential and reducing the competitive threats. 3-Adocacy - assists you in the implementation of your actionnable plan to boost your venture performance. Please … Type: | 0 | 0 | 0 | 1 |
 | Polyneuron Pharmaceuticals AG Precision treatment of immune disorders Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-CatchTM technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients. Type: | 2 | 1 | 0 | 4 |
 | Vicept Therapeutics, Inc Start-up Dermatology Company. Type: | 13 | 1 | 0 | 1 |
 | Quantgene We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 4 | 0 | 4 | 39 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | eXmoor Pharma eXmoor is a full service Cell & Gene Therapy CDMO, backed by over 20 years manufacturing experience for 150+ clients eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients. We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the … Type: | 1 | 0 | 1 | 78 |
 | OxyNov Revolutionizing oxygen therapy with the FreeO2: a device that optimizes every stage of treatment during hospital care. We are and want to remain pioneers in offering powerful, innovative, and cutting-edge technologies to oxygen therapy care. Our mission is to overcome the current limitations of respiratory care and oxygen therapy to : - Improve the safety and quality of life of patients. - Optimize care in a context of increasing number of patients and of hospitalization cost control. Our flagship device, the FreeO2, an automated oxygen therapy system : - Adjusts oxygen flow to the patient's needs in real time, avoiding … Type: | 3 | 1 | 1 | 15 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 3 | 0 | 3 | 18 |
 | Bioretec Ltd. better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery Type: | 0 | 0 | 0 | 43 |
 | Novostia Heart valves for life, for patients of any age, including children Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com Heart Valves and Medical Devices Type: | 0 | 0 | 0 | 16 |
 | BÜHLMANN Laboratories AG BÜHLMANN is a fully independent, medium sized and family owned Swiss company. Founded in 1976, BÜHLMANN today has local teams in Switzerland, France, Italy, Germany, Austria, USA and Brazil and distributors worldwide. BÜHLMANN has become the prime calprotectin company within few years, offering the broadest range of calprotectin assays from fully automatable, high-throughput turbidimetric and ELISA assays, BÜHLMANN fCAL® turbo and BÜHLMANN fCAL® ELISA, to the point-of-care quantitative Quantum Blue® and IBDoc® home test application. Additional to calprotectin assays, BÜHLMANN offers therapeutic drug monitioring solutions for biologics used in chronic inflammatory diseases. BÜHLMANN does not only stand for calprotectin, but … Type: | 0 | 0 | 0 | 114 |
 | SeeO2 Energy Inc. Fuels and chemicals from CO2 SeeO2 Energy Inc. vision is to efficiently convert captured CO2 and/or water to fuels and chemicals using reversible solid oxide fuel cell technology. We provide our customers in the chemicals, metal processing, polymers, and utilities industries with a reliable, onsite and cost competitive industrial feedstocks for their products. ELECTROCHEMISTRY, Solid Oxide Fuel Cells, Solid Oxide Electrolysis Cells, Power to Gas, CO2 to Fuels, Reversible Fuel Cells, Electrolysers, Power to fuels, H2O electrolysis, CO2 electrolysis, and CO2 utilization Type: | 2 | 1 | 1 | 5 |
 | Diatech Pharmacogenetics Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions … Type: | 3 | 1 | 1 | 62 |
 | Sus Clinicals, Inc. Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. Type: | 0 | 0 | 0 | 17 |
 | WINPRO Pet Harnessing The Power Of Clinically Proven Blood Proteins To Help Your Dog Stay Healthy, Active, And With You. WINPRO is the world's first and only line of blood protein supplements. WINPRO products use the power of clinically proven animal blood proteins to help prevent and combat the negative effects of stress-induced inflammation in dogs. Many of today's most common canine health problems are caused by inflammation which is often caused by stress. Type: | 0 | 0 | 0 | 5 |
 | ELIAS Animal Health Changing the way cancer is fundamentally treated. ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Our approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. The ELIAS Cancer Immunotherapy (ECI®) works by conditioning the immune system to recognize a patient’s unique cancer, and then delivering an army of activated killer T cells to specifically target and attack those cancer cells. Learn more at eliasanimalhealth.com. Type: | 0 | 0 | 0 | 10 |
 | Loyal Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs. Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to … Type: | 0 | 0 | 0 | 201 |
 | Microbiologics The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug … Type: | 1 | 0 | 2 | 351 |
 | Pinney Associates, Inc. Guiding Pharmaceutical and Consumer Healthcare Companies to Success Pharmaceutical and consumer healthcare companies work within dynamic, sometimes unpredictable, regulatory and commercial environments. Pinney Associates' multidisciplinary teams anticipate your scientific and policy obstacles while guiding you toward regulatory and marketplace success. Pharmaceuticals, Risk Management, Abuse Liability Testing, Rx to OTC Switch, In vitro, Abuse potential assessment, Consumer healthcare, Consumer insights, Business development, FDA, CNS active drugs, Regulatory, Over-the-counter medicines, OTCs, Nonprescription drugs, Dietary supplements, Regulatory Strategy, Clinical Development, Eight Factor Analysis 8FA, Abuse Deterrent Formulation Evaluation, Postmarketing Surveillance, Risk Evaluation and Mitigation Strategies, REMS, Target Product Profiles, Scientific Assessment and Review, … Type: | 4 | 0 | 4 | 28 |
 | CONMED Foot & Ankle A Division of CONMED Corporation CONMED Foot & Ankle proudly offers surgeons a comprehensive portfolio of tailored and simplified solutions for foot and ankle procedures. We specialize in designing and manufacturing unique products to address unmet clinical needs and improve surgical outcomes and patient care. We are proud to be forerunners in developing solutions for sterile implants and single-use instrumentation. For more information, or if you wish to be contacted, please visit www.conmed.com/footandankle. Foot and Ankle , Medical Device, Small Joint Implants, Nitinol Staples, Plates, Cannulated Bone Screws, Sterile Portfolio , Orthopedics, Extremities, Ankle, Bunion, and Lapidus Type: | 0 | 0 | 0 | 70 |
 | RTI Health Solutions Providing the trusted research and strategic planning services you need for your drug or medical device. RTI Health Solutions' integrated project teams are here to help you with your pharmaceutical and medical device research needs. Our robust and trusted methods provide answers to the research questions relevant to your drug or device. Our experienced teams are with you throughout your product's lifecycle to ensure you have the evidence you need when you need it. They continuously monitor your portfolio of projects to keep them flowing seamlessly—enabling you to focus your time elsewhere. Follow us @RTIHS on Twitter too. We are … Type: | 2 | 0 | 2 | 369 |
 | Coridea Global Medical Device Incubator with specialty in Cardiac, Pulmonary, and Renal Innovation INNOVATION Coridea is a premier medical device incubator driven by an innovative and translational health care approach. Coridea develops unexpected device solutions that change the lives of cardiology, pulmonary and renal patients who have no other treatment options. INVENTION Coridea is a leading inventor in the medical device arena and has a proven track record of generating innovative technology and converting it into high impact solutions for patients and high value returns for investors. SUCCESS Coridea has successfully launched six cardiology and renal focused companies in the past … Type: | 0 | 0 | 0 | 9 |
 | Ra Medical Systems Our Mission: Save lives, limbs and improve patients’ quality of life. Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity. In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for crossing … Type: | 2 | 2 | 0 | 38 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … Type: | 4 | 1 | 2 | 141 |
 | Laboratorios Syva Soluciones con Sentido para la Salud Animal - Meaningful Solutions for Animal Health Our mission is to provide efficient solutions for the permanent improvement of animal health, creating value for the client through the commitment and capacity of our human team. Laboratorios Syva researches, develops, manufactures and commercializes biological and pharmaceutical products for the veterinary sector, with own subsidiaries in Spain, Portugal and Mexico, and a presence in more than 70 countries worldwide through a network of business partners and distributors. Veterinary biologicals, Veterinary pharmaceuticals, Veterinary antimicrobials, Vaccines, Bienestar animal, CMO, Contract manufacturing, and R&D Type: | 1 | 0 | 1 | 252 |
 | Nikon Instruments Nikon Instruments is the Microscope division of Nikon Healthcare and a leader in optical and imaging technologies. Nikon Instruments Inc. is a leading provider of microscopes, cameras, and related technologies for the clinical, educational, research, biotech, and other markets. With over 100 years of optical experience, Nikon is a global leader with a long history of innovation that continues to set the standard for quality and reliability. Nikon Instruments Inc. belongs to the Nikon Corporation Healthcare Business Unit, whose mission is to advance healthcare and provide a better quality of life while promoting creativity and trustworthiness. Nikon remains the only … Type: | 2 | 0 | 1 | 502 |
 | BINDER GmbH Best conditions for your success --- BINDER - Best conditions for your success The world's largest specialist in simulation chambers for the scientific and industrial laboratory. Whether cold testing, heat testing, stress testing, stability testing or drying paint, when developing our products we have but one goal: to provide the perfect solution for exactly your area of application in the scientific and industrial laboratory. Clients include: Bayer, BASF, Novartis, Aventis, Schering Plough, Max Planck Institute, Bayer Pharma, Byk Gulden, Boehringer Ingelheim, DKFZ, Daimler, Bosch, Siemens, Toyota, Philip Morris, Kraft Food, Nestlé and many more! Microbiological Incubators and Heating Ovens for … Type: | 1 | 0 | 0 | 232 |
 | Gilson Gilson provides high quality, dependable solutions for today's demanding liquid chromatography, solid phase extraction, liquid handling and gel permeation chromatography clean-up requirements. From the legendary PIPETMAN® products to a full range of system solutions, Gilson is the element of purification for your laboratory. Gilson has worldwide sales and service supporting the pharmaceutical, biotech, environmental, clinical, food & beverage and forensic markets. Our primary focus is on purifying samples via preparative HPLC, automated SPE or through GPC clean-up. Gilson focuses on early drug discovery and development with our preparative HPLC systems. Gilson's automated SPE systems and GPC clean-up systems support environmental, … Type: | 4 | 3 | 0 | 488 |
 | Dômes Pharma US Sentrx Animal Care, Inc. is now a part of Dômes Pharma Group. Dômes Pharma, an independent family-owned group, a pioneer in animal health, has been developing, manufacturing and marketing solutions for the health and well-being of pets since 1947. Established in Auvergne in central France, the region of volcanoes and its domes from which it takes its name, in 2016 the Group began its international expansion by opening subsidiaries in the UK, Germany, Spain and the USA. In July 2023, the Group acquired the American company Sentrx Animal Care based in Salt Lake City (Utah), which develops and manufactures ophthalmology … Type: | 1 | 0 | 0 | 14 |
 | Destiny Pharma Limited Infection prevention biotech with late-stage assets targeting C. difficile and post-surgical S. aureus infections Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections including MRSA. It … Type: | 1 | 0 | 1 | 24 |
 | SolasCure Transforming chronic wound care with a breakthrough wound therapeutic Chronic wounds affect ~100m people around the world, impacting quality of life & placing a huge burden on health systems. Despite the many innovations in wound care over the years, chronic wound healing rates have barely improved. Change is needed – patients, practitioners, and regulators across the industry are in urgent need of high-impact innovations in chronic wound care. SolasCure is at the forefront of addressing this demand, aiming to shift the current treatment paradigm with a high impact therapeutic approach to debridement, with the goal of enabling dramatic improvements in … Type: | 2 | 1 | 1 | 17 |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. To achieve this, we are focused on unlocking the potential value of our robust ADC portfolio across two pillars of growth: hematology and solid tumors. We are a pioneer in the ADC field with specialized end-to-end capabilities unique to ADCs including a validated technology platform, a growing next-generation research & development toolbox and a proven track record that includes an approved and marketed … Type: | 2 | 0 | 2 | 307 |
 | PROTEROS biostructures GmbH REACH RIGHT FASTER Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan. For more information please visit www.proteros.com. As we continue to grow, we constantly look for committed, professional and energetic people with a high sense of … Type: | 2 | 0 | 2 | 135 |
 | Mewery The first European startup cultivating pork meat on a proprietary microalgae base Mewery is the first European foodtech startup developing cultivated pork on microalgae base. Thanks to Mewery, people all over Europe, Asia and further will be able to enjoy real pork meat, juicy and healthy, but with one huge difference: without having to kill a single pig or harming the planet. Mewery is using their own hybrid culture medium with microalgae extracts and developing 3D structures on microalgae scaffolds. pork cell lines, culture media, proprietary growth factors, microalgea expertise, cultivated pork product line, cellular agrculture, and cell-based meat Type: | 4 | 2 | 2 | 8 |
 | GlycoEra AG Advancing Glycan Mediated Therapy GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention. Glycoengineering, Therapeutic product development, and Biopharmaceutical CMC development Type: | 1 | 0 | 1 | 37 |
 | RIBOPRO Dream ahead. RIBOPRO is an innovative service provider, producing high-quality, high-performance RNA products, which are used as powerful research tools and therapeutics. RiboPro offers both off-the-shelf and custom RNA products at competitive rates and turn-around times, effectively removing all barriers to successful use of RNA in the research and development of our customers. We have more than 2 years experience satisfying the RNA-related needs of our (returning!) customers and thus we are confident that we can help you get your next project off to a good start. Let us worry about the quality and performance of your RNA, so you … Type: | 0 | 0 | 0 | 30 |
 | Tempty Foods Foods of the future based on mycelium (fermented "roots of mushrooms"). 🍄🟫🌱 We are a Danish food innovation company, creating the foods of the future based on mycoprotein (fungi). 🌱🍄 Our first product, TEMPTY, is the next-generation food ingredient offering a great taste experience instead of imitating meat. TEMPTY is made of mycoprotein from fungi, the secret behind the exceptional texture and delicate umami flavor of our products. 🍄 In Tempty Foods, we are on a mission to bring sustainable innovation to everyone’s plates! 🌍 Stay tempted, more products are coming! Food innovation, Mycoprotein, Alternatives to meat, Green proteins, and … Type: | 2 | 2 | 0 | 6 |
 | Sylvia Health A simple and effective way for every woman to manage pelvic organ prolapse Sylvia Health is actively developing a non-surgical solution for pelvic organ prolapse, a condition impacting 8% of all women. Existing treatment options are inadequate. Surgery is painful and too often ineffective, whereas pessaries are abandoned by half of users within a year. Guided by the ongoing input of women, Sylvia’s solution is meticulously crafted for precise support and ease of use, empowering women to reclaim their quality of life. Connect with us, explore our page, and visit our website (link below) to stay informed about our journey … Type: | 0 | 0 | 0 | 2 |
 | EVERSENS SL What you breath reveals We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test. I+D, Biomarcadores exhalados, Óxido Nítrico, Fabricación, Comercialización, ISO13485, Dispositivos Médicos, Patentes, eHealth, R&D, Exhaled Biomarkers, Nitric Oxide, Manufacturing, Commercialization, Medical Devices, Patents, FeNO, and Asthma diagnostic and management Type: | 7 | 0 | 0 | 10 |
 | Bioceltix Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a biotech start-up which deals with the development of stem cell-based medicinal products for veterinary use. Currently, our main goal is to implement a biopharmaceuticals based on allogenic stem cells. The medicines will be primarily to serve the treatment of accompanying animals. The new product candidates will become a milestone in the field of stem cell-based biopharmaceuticals for veterinary use. As one of the first such Europe-based company, Bioceltix product intends to go through the full registration path to a marketed drugs devised … Type: | 0 | 0 | 0 | 27 |
SMB